# DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

> **NCT05517291** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Safety Issues
- Efficacy, Self

## Interventions

- **DEVICE:** paclitaxel-coated balloon angioplasty or bare mental stents implantation

## Key facts

- **NCT ID:** NCT05517291
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-18
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05517291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05517291, "DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05517291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*